skip to content

Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID)

 
Read more at: Professor Yorgo Modis leads collaborative project on MORC2-related disorder

Professor Yorgo Modis leads collaborative project on MORC2-related disorder

24 February 2026

Professor Yorgo Modis (Department of Medicine, University of Cambridge) is leading a research project with MORCure , a patient-led global charity that leads research, innovation and best practice for individuals with MORC2-related disorder (M2RD), to generate new insights into how genetically inherited variants of the...


Read more at: CITIID receives Silver LEAF award for sustainability

CITIID receives Silver LEAF award for sustainability

28 January 2026

CITIID has achieved the Silver LEAF accreditation in recognition of exemplary actions undertaken to improve the sustainability practices as part of the laboratory efficiency assessment framework (LEAF). certificate_silver_2026-01-12_11_27_14_1_page-0001.jpg Building on last year's Bronze LEAF award, the CITIID...


Read more at: Hidden mpox exposure detected in healthy Nigerian adults, revealing under-recognised transmission

Hidden mpox exposure detected in healthy Nigerian adults, revealing under-recognised transmission

20 January 2026

In a study published today in Nature Communications , Dr Adam Abdullahi, Professor Ravindra Gupta and colleagues show that exposure to the mpox virus can occur without recognised illness, and that residual immunity from historic smallpox vaccination continues to shape how the virus spreads in human populations.


Read more at: Bird flu viruses are resistant to fever, making them a major threat to humans

Bird flu viruses are resistant to fever, making them a major threat to humans

28 November 2025

In a study published today in Science, Professor Sam Wilson and colleagues identified a gene that plays an important role in setting the temperature sensitivity of a virus. In the deadly pandemics of 1957 and 1968, this gene transferred into human flu viruses, and the resulting virus thrived.


Read more at: Advancing typhoid vaccine in Africa

Advancing typhoid vaccine in Africa

14 November 2025

Cambridge, Seoul and Ghana are working together to bring life-saving solutions across the continent to communities at risk.


Read more at: HKJCGHI hosts plaque-unveiling ceremony to launch headquarters and a joint lab with Cambridge to drive global health innovation

HKJCGHI hosts plaque-unveiling ceremony to launch headquarters and a joint lab with Cambridge to drive global health innovation

20 October 2025

The Hong Kong Jockey Club Global Health Institute (HKJCGHI) proudly celebrated a significant milestone today (17 October) with the unveiling of its headquarters and a cutting-edge joint laboratory with the University of Cambridge (UCAM) located at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed). This...


Read more at: New study charts the cellular landscape of iron control
Photo of Anthony Martinelli and James Nathan

New study charts the cellular landscape of iron control

6 October 2025

Work led by Anthony Martinelli in James Nathan ’s group (CITIID, Medicine), now published in Science Advances , provides the first comprehensive map of the critical genes that regulate iron within our cells. Iron is a classic double-edged sword: essential for life, yet toxic in excess. This new map of the cell’s iron-...


Read more at: Connecting minds, shaping frontiers: Department of Medicine Annual Research Day 2025
Picture of audiences at the Robinson College

Connecting minds, shaping frontiers: Department of Medicine Annual Research Day 2025

22 September 2025

Our Annual Research Day is the largest forum for presenting research by faculty, staff, and trainees in the Department of Medicine.


Read more at: Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial

Safety and immunogenicity of fractional COVID-19 vaccine doses in Nigerian adults: A randomized non-inferiority trial

4 August 2025

Recent publication in Scientific Reports from a large collaborative effort led by Professor Ravi Gupta showing that fractional doses of COVID-19 vaccine elicit comparable neutralising antibody responses to variants of concern as full dose vaccine in the west African setting.


Read more at: Cold sore virus immediately reshapes our genome to boost its growth

Cold sore virus immediately reshapes our genome to boost its growth

15 July 2025

Benjamin Krishna commented in New Scientist on new research that has identified an experimental cancer drug that could help treat the HSV-1 virus in people with severe cold sores or those who have a suppressed immune system.